Drugs that contain Testosterone

1. List of Androgel drug patents

ANDROGEL's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8466137 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8754070 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8729057 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8741881 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8466138 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8466136 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8486925 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

US8759329 ABBVIE Testosterone gel and method of use
Oct, 2026

(3 years from now)

Market Authorisation Date: 29 April, 2011

Treatment: Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone

Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL

More Information on Dosage

ANDROGEL family patents

14

United States

3

European Union

2

Denmark

2

Slovenia

2

Norway

2

Portugal

2

Cyprus

2

Spain

2

Poland

2

Japan

1

Israel

1

South Africa

1

Turkey

1

Australia

1

Hong Kong

1

Lithuania

1

Morocco

1

Croatia

1

Brazil

1

Korea, Republic of

1

RS

1

China

1

Ecuador

1

Georgia

1

Ukraine

EA

1

EA

1

Canada

1

Tunisia

1

New Zealand

2. List of Axiron drug patents

AXIRON's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784878 ELI LILLY AND CO Transdermal delivery rate control using amorphous pharmaceutical compositions
Jul, 2023

(3 months from now)

US9180194 ELI LILLY AND CO Method and composition for transdermal drug delivery
Jun, 2026

(3 years from now)

US8993520 ELI LILLY AND CO Method and composition for transdermal drug delivery
Jun, 2026

(3 years from now)

US8419307 ELI LILLY AND CO Spreading implement
Feb, 2027

(3 years from now)

US8807861 ELI LILLY AND CO Spreading implement
Feb, 2027

(3 years from now)

US9289586 ELI LILLY AND CO Spreading implement
Feb, 2027

(3 years from now)

US8435944 ELI LILLY AND CO Method and composition for transdermal drug delivery
Sep, 2027

(4 years from now)

Market Authorisation Date: 23 November, 2010

Treatment: A method of transdermally delivering testosterone; A method of increasing the testosterone blood level of an adult male subject in need thereof; A method of increasing the testosterone blood level of ...

Dosage: SOLUTION, METERED;TRANSDERMAL

How can I launch a generic of AXIRON before it's patent expiration?
More Information on Dosage

AXIRON family patents

16

United States

8

Australia

5

Japan

5

Korea, Republic of

4

European Union

3

Brazil

EA

3

EA

3

Canada

3

New Zealand

3

China

2

Hong Kong

2

South Africa

2

Mexico

2

Spain

1

India

3. List of Natesto drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784882 ACERUS Controlled release delivery system for nasal applications and method of treatment
Feb, 2024

(10 months from now)

US8877230 ACERUS Controlled release delivery system for nasal applications
Feb, 2024

(10 months from now)

US8574622 ACERUS Controlled release delivery system for nasal applications
Feb, 2024

(10 months from now)

US8784869 ACERUS Controlled release delivery system for nasal applications and methods of treatment
Feb, 2024

(10 months from now)

US11090312 ACERUS Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
Mar, 2034

(10 years from now)

Market Authorisation Date: 28 May, 2014

Treatment: A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation.; Nasal administrat...

Dosage: GEL, METERED;NASAL

More Information on Dosage

NATESTO family patents

32

United States

IB

2

IB

2

European Union

1

South Africa

1

Denmark

1

Austria

1

Australia

1

Russia

1

Slovenia

1

Norway

1

Germany

1

Argentina

1

Brazil

1

Croatia

1

Portugal

1

Malaysia

1

Spain

1

Korea, Republic of

1

Poland

1

Taiwan, Province of China

1

Japan

1

Canada

4. List of Testim drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7608605 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7608610 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7608608 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7608606 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US8063029 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US8178518 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7935690 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7608609 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7608607 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(18 days from now)

US7320968 AUXILIUM PHARMS LLC Pharmaceutical composition
Jan, 2025

(1 year, 9 months from now)

Market Authorisation Date: 31 October, 2002

Treatment: Method for administration of testosterone

Dosage: GEL;TRANSDERMAL

How can I launch a generic of TESTIM before it's patent expiration?
More Information on Dosage

TESTIM family patents

23

United States

3

Hong Kong

2

Argentina

2

Spain

2

Korea, Republic of

2

Iceland

2

China

2

European Union

1

Israel

1

South Africa

1

Denmark

1

Austria

1

Mexico

1

Australia

1

Egypt

1

Saudi Arabia

1

Lithuania

1

Latvia

1

Norway

1

Germany

1

Brazil

1

Cyprus

1

Malaysia

1

Poland

1

Taiwan, Province of China

1

Japan

EA

1

EA

1

Canada

1

New Zealand

5. List of Vogelxo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9662340 UPSHER SMITH LABS Testosterone gel compositions and related methods
Feb, 2034

(10 years from now)

US9295675 UPSHER SMITH LABS Testosterone gel compositions and related methods
Feb, 2034

(10 years from now)

US8785426 UPSHER SMITH LABS Testosterone gel compositions and related methods
Feb, 2034

(10 years from now)

Market Authorisation Date: 04 June, 2014

Treatment: Method for transdermal delivery of testosterone

Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL

More Information on Dosage

VOGELXO family patents

5

United States

1

Hong Kong

1

Singapore

1

South Africa

1

Canada

1

Australia

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic